• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SR141716对大鼠蔗糖奖励操作性反应中强化后停顿的作用。

Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats.

作者信息

Pério A, Barnouin M C, Poncelet M, Soubrié P

机构信息

Centre de Recherche Sanofi-Synthélabo, Montpellier, France.

出版信息

Behav Pharmacol. 2001 Dec;12(8):641-5. doi: 10.1097/00008877-200112000-00009.

DOI:10.1097/00008877-200112000-00009
PMID:11856902
Abstract

Cannabinoids increase food intake, via CB1 receptors. The CB1 antagonist, SR141716, has been reported to decrease palatable food consumption in both operant and non-operant procedures. Similarly, CB1 receptor blockade diminished responding for normal food pellets under a fixed-ratio 15 (FR-15) schedule of reinforcement. The present experiment investigated whether the control of a continuous schedule of reinforcement (CRF) for sucrose pellets would be sensitive to the CB1 antagonist in mildly deprived rats. SR141716 dose-dependently reduced responding in a CRF procedure, by increasing post-reinforcement pauses. Together with formerly published conclusions, the data suggest that CB1 blockade reduces the rewarding efficacy of both palatable and non-palatable food.

摘要

大麻素通过CB1受体增加食物摄入量。据报道,CB1拮抗剂SR141716在操作性和非操作性程序中均可减少美味食物的摄入量。同样,在固定比例15(FR-15)强化程序下,CB1受体阻断减少了对正常食物颗粒的反应。本实验研究了在轻度饥饿的大鼠中,对蔗糖颗粒连续强化程序(CRF)的控制是否对CB1拮抗剂敏感。SR141716在CRF程序中通过增加强化后停顿,剂量依赖性地减少反应。与先前发表的结论一致,数据表明CB1阻断降低了美味和非美味食物的奖赏效力。

相似文献

1
Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats.SR141716对大鼠蔗糖奖励操作性反应中强化后停顿的作用。
Behav Pharmacol. 2001 Dec;12(8):641-5. doi: 10.1097/00008877-200112000-00009.
2
Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.大麻素CB1受体拮抗剂利莫那班对大鼠巧克力味饮料强化和激励特性的抑制作用。
Behav Pharmacol. 2008 May;19(3):197-209. doi: 10.1097/FBP.0b013e3282fe8888.
3
Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.大麻素CB1受体拮抗剂可减弱可卡因的奖赏效应:大鼠自我给药及脑刺激奖赏实验
Neuropsychopharmacology. 2008 Jun;33(7):1735-45. doi: 10.1038/sj.npp.1301552. Epub 2007 Aug 29.
4
The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.CB1 拮抗剂利莫那班(SR141716)阻断线索诱导的可卡因觅药行为复发以及其他预测复发的情境和消退现象。
Drug Alcohol Depend. 2009 Dec 1;105(3):248-55. doi: 10.1016/j.drugalcdep.2009.07.002. Epub 2009 Aug 12.
5
The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940).CB1受体在甜味与脂肪强化中的作用:CB1受体缺失、CB1受体拮抗(SR141716A)及CB1受体激动(CP - 55940)的影响
Behav Pharmacol. 2005 Sep;16(5-6):381-8. doi: 10.1097/00008877-200509000-00010.
6
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.利莫那班,一种CB1拮抗剂,可阻断尼古丁条件性位置偏好。
Neuroreport. 2004 Sep 15;15(13):2139-43. doi: 10.1097/00001756-200409150-00028.
7
Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study.大麻素受体拮抗剂SR141716A急性给药对未接触过大麻素和已产生耐受性动物的功能影响:一项定量2-[14C]脱氧葡萄糖研究。
Brain Res. 2003 Feb 7;962(1-2):169-79. doi: 10.1016/s0006-8993(02)03999-9.
8
Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats.大麻素CB1受体拮抗剂SR - 141716A对大鼠乙醇自我给药及觅酒行为的影响。
Psychopharmacology (Berl). 2006 Jan;183(4):394-403. doi: 10.1007/s00213-005-0199-9. Epub 2005 Oct 29.
9
Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.大麻素CB1受体拮抗剂利莫那班(SR141716)对喹氯烷增强食物引发的觅食行为恢复的阻断作用。
Neuropsychopharmacology. 2004 May;29(5):911-20. doi: 10.1038/sj.npp.1300370.
10
Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.大麻素和阿片类药物对食物强化的激励作用取决于大麻素和阿片类系统的同时激活。
Neuropsychopharmacology. 2005 Nov;30(11):2035-45. doi: 10.1038/sj.npp.1300720.

引用本文的文献

1
Endocannabinoid System Regulation in Female Rats with Recurrent Episodes of Binge Eating.反复暴饮暴食的雌性大鼠体内内源性大麻素系统的调节
Int J Mol Sci. 2022 Dec 3;23(23):15228. doi: 10.3390/ijms232315228.
2
Hedonic and incentive signals for body weight control.体重控制的享乐和激励信号。
Rev Endocr Metab Disord. 2011 Sep;12(3):141-51. doi: 10.1007/s11154-011-9166-4.
3
Role of endocannabinoid signaling in anxiety and depression.内源性大麻素信号传导在焦虑和抑郁中的作用。
Curr Top Behav Neurosci. 2009;1:347-71. doi: 10.1007/978-3-540-88955-7_14.
4
Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists.详细分析食物强化操作性压杆反应可区分大麻素 CB1 反向激动剂与多巴胺 D1 和 D2 拮抗剂的作用。
Pharmacol Biochem Behav. 2010 Jul;96(1):75-81. doi: 10.1016/j.pbb.2010.04.009. Epub 2010 Apr 18.
5
Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates.大麻素拮抗剂SR141716(利莫那班)和右旋苯丙胺对非人灵长类动物可口食物和食物颗粒摄入量的影响。
Pharmacol Biochem Behav. 2007 Apr;86(4):766-73. doi: 10.1016/j.pbb.2007.03.004. Epub 2007 Mar 15.
6
A comparison of the effects of the CB(1) receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour.CB(1)受体拮抗剂SR141716A、预喂食和适口性改变对摄食行为微观结构影响的比较
Psychopharmacology (Berl). 2007 Jul;193(1):1-9. doi: 10.1007/s00213-007-0745-8. Epub 2007 Mar 20.
7
Reduced sensitivity to reward in CB1 knockout mice.CB1基因敲除小鼠对奖励的敏感性降低。
Psychopharmacology (Berl). 2004 Nov;176(2):223-32. doi: 10.1007/s00213-004-1877-8. Epub 2004 Apr 9.